이명 치료 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Ringing Ears Treatment Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,828,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,972,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,613,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계 이명 치료 시장에 대한 심층 분석을 통해 시장 역학, 성장 촉진요인, 과제 및 신흥 동향에 대한 인사이트를 제공합니다. 이 보고서는 2024년부터 2031년까지의 시장 상황을 탐색할 수 있는 상세한 데이터와 통계를 제공하며, 이해관계자들에게 귀중한 자료가 될 것입니다.

세계 이명 치료 시장은 2024년부터 2031년까지 2.8%의 연평균 성장률(CAGR)로 큰 폭의 성장이 예상됩니다. 시장은 2024년 26억 달러에서 2031년 말에는 32억 달러로 확대될 것으로 예상됩니다.

주요 인사이트

• 추정 시장 가치(2024년) : 26억 달러
• 예상 시장 가치(2031년) : 32억 달러
• 세계 시장 성장률(2024-2031년 CAGR) : 2.8%

이명 치료 시장 : 연구 범위

이명의 유병률 증가와 의료 기술의 발전은 이명 치료 시장의 성장을 촉진하고 있습니다. 이명은 귀가 울리거나 윙윙거리는 소리를 특징으로 하며, 전 세계 인구의 상당수가 앓고 있는 질환입니다. 소음성 난청, 노화성 난청, 시끄러운 환경에 노출되는 등의 요인이 이명의 발병에 기여하고 있습니다. 이명이 삶의 질에 미치는 영향에 대한 인식이 높아짐에 따라 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 음향 치료 기기, 인공와우, 약물 치료와 같은 기술 혁신은 이명 환자들의 미충족 수요를 충족시키는 데 중요한 역할을 하고 있습니다.

시장 성장 촉진요인:

이명 치료 시장은 이명 유병률 증가, 의료 기술 발전, 청력 건강에 대한 인식 증가 등 다양한 요인에 의해 주도되고 있습니다. 노인 인구의 증가와 노인성 난청의 증가로 인해 이명 관리 솔루션에 대한 수요가 증가하고 있습니다. 또한, 소음 공해가 청력 건강에 미치는 영향은 예방 조치와 치료 옵션의 필요성을 증가시키고 있습니다. 보청기 및 음향 치료 장비의 기술 발전과 이명의 근본적인 메커니즘을 규명하는 데 중점을 둔 연구 활동이 시장 성장에 기여하고 있습니다.

시장 억제요인:

이명 치료에 대한 수요가 증가하고 있음에도 불구하고, 시장은 제한된 치료 효과와 높은 비용이라는 문제에 직면해 있습니다. 이명은 다양한 원인을 가진 복잡한 증상이기 때문에 보편적인 치료 솔루션을 개발하기 어렵습니다. 또한, 이명의 증상은 주관적이고, 치료에 대한 환자의 반응은 개인차가 있어 의료진에게 어려움을 주고 있습니다. 또한, 인공와우나 신경조절장치와 같은 고급 치료 옵션은 고가이기 때문에 특정 환자군의 접근성이 제한되어 있습니다. 규제적 장애물과 상환 문제는 이명 치료 시장의 이해관계자들이 직면한 과제를 더욱 복잡하게 만들고 있습니다.

시장 기회:

이명 치료 시장은 업계 이해관계자들 간의 기술 혁신과 협력에 큰 기회가 있습니다. 신경과학, 디지털 헬스, 개인 맞춤형 의료의 발전은 이명 환자들을 위한 효과적인 치료법을 개발할 수 있는 새로운 길을 제공하고 있습니다. 인공지능과 기계학습 알고리즘을 진단 및 치료 접근법에 통합하면 치료 성과와 환자 만족도를 높일 수 있습니다. 또한, 이명의 신경생물학적 메커니즘을 규명하고 새로운 치료 타깃을 발굴하는 데 초점을 맞춘 연구 활동을 확대함으로써 이 분야의 혁신을 촉진할 수 있습니다. 이명 연구를 발전시키고 환자 치료를 개선하기 위해서는 학계, 산업계 및 환자 지원 단체의 협력이 필수적입니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 이명 치료 혁신/주요 개발 동향
• 신발매/절차/특허

제4장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제5장 시장 상황

• 제조업체 및 공급업체 리스트
• 사용 상황/채용 분석
• 질병 역학
• 주요 제조업체에 의한 프로모션 전략
• FDA 승인 이명 치료 기기 리스트

제6장 COVID-19 위기 분석

• COVID-19의 현재 통계와 향후의 영향 가능성
• 현재 GDP 예측과 예상되는 영향
• 현재 경제 예측과 2008년 재무 분석의 비교
• COVID-19와 영향 분석
  • 제품별 매출
  • 국가별 매출
• 2021년 시장 시나리오
• 분기별 예측
• 회복 예측 분기
• 회복 시나리오-단기, 중기, 장기의 영향

제7장 이명 치료 시장 - 가격 분석

• 적응증별 지역별 가격 분석
• 가격 내역
  • 제조업체 레벨 가격 설정
  • 유통업체 레벨 가격 설정
• 평균 가격 분석 벤치마크

제8장 세계의 이명 치료 시장 분석과 예측(수량)

• 과거 시장 분석(수량), 2019-2023년
• 현재 및 향후 시장 예측(수량), 2024-2031년
  • 전년비 성장 동향 분석

제9장 세계의 이명 치료 시장 분석과 예측(금액)

• 과거 시장 분석(금액), 2019-2023년
• 현재 및 향후 시장 예측(금액), 2024-2031년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회 분석

제10장 세계의 이명 치료 시장 분석과 예측, 제품별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2031년
  • 디바이스
    • 사운드 마스킹 디바이스
    • 노치형 음악 디바이스
    • 보청기
  • 약물
    • 삼환계 항우울제
    • 항불안제
    • 항경련제
• 제품별 시장 매력도 분석

제11장 세계의 이명 치료 시장 분석과 예측, 적응증별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2031년
  • 주관적 이명
  • 객관적 이명
  • 적응증별 시장 매력도 분석

제12장 세계의 이명 치료 시장 분석과 예측, 유통 채널별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2031년
  • 청각 센터
  • 이비인후과 클리닉
  • 병원
  • E-Commerce
• 유통 채널별 시장 매력도 분석

제13장 세계의 이명 치료 시장 분석과 예측, 지역별

• 소개
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2031년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장 매력도 분석

제14장 북미의 이명 치료 시장 분석과 예측

제15장 라틴아메리카의 이명 치료 시장 분석과 예측

제16장 유럽의 이명 치료 시장 분석과 예측

제17장 남아시아의 이명 치료 시장 분석과 예측

제18장 동아시아의 이명 치료 시장 분석과 예측

제19장 오세아니아의 이명 치료 시장 분석과 예측

제20장 중동 및 아프리카의 이명 치료 시장 분석과 예측

제21장 신흥 국가의 이명 치료 시장 분석과 예측

• 소개
  • 주요 국가별 시장 금액 비율 분석
  • 세계와 국가별 성장 비교
• 미국
• 캐나다
• 멕시코
• 브라질
• 영국
• 독일
• 프랑스
• 이탈리아
• 스페인
• 베네룩스
• 러시아
• 중국
• 일본
• 한국
• 인도
• ASEAN
• 호주
• 뉴질랜드
• GCC 국가
• 터키
• 남아프리카공화국

제22장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석

제23장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical
  • GlaxoSmithKline
  • Eli Lilly and Co.
  • Bayer AG
  • Takeda Pharmaceutical Company Ltd.
  • Boehringer Ingelheim
  • Merck &Co.
  • Abbivie
  • Starkey Laboratories, Inc.
  • GN Hearing A/S
  • Widex A/S
  • Oticon Inc.
  • Neuromod Devices Ltd.
  • Neuromonics, Inc.
  • Puretone Ltd.
  • Signia

제24장 사용되는 가정과 두문자어

제25장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has conducted an in-depth analysis of the global Ringing Ears Treatment Market, providing insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a valuable resource for stakeholders, offering detailed data and statistics to navigate the market landscape from 2024 to 2031.

The global ringing ears treatment market is projected to witness substantial growth, with a forecasted CAGR of 2.8% during the period from 2024 to 2031. The market is expected to expand from an estimated value of US$ 2.6 Bn in 2024 to US$ 3.2 Bn by the end of 2031.

Key Insights:

• Estimated Market Value (2024): US$ 2.6 Bn
• Projected Market Value (2031): US$ 3.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 2.8%

Ringing Ears Treatment Market - Report Scope:

The increasing prevalence of tinnitus, coupled with advancements in medical technology, is driving the growth of the ringing ears treatment market. Tinnitus, characterized by ringing or buzzing sounds in the ears, affects a significant portion of the global population. Factors such as noise-induced hearing loss, age-related hearing loss, and exposure to loud environments contribute to the development of tinnitus. As awareness about tinnitus and its impact on quality of life grows, the demand for effective treatment options is rising. Technological innovations, including sound therapy devices, cochlear implants, and pharmaceutical interventions, are playing a key role in addressing the unmet needs of tinnitus patients.

Market Growth Drivers:

The ringing ears treatment market is driven by various factors, including the increasing prevalence of tinnitus, advancements in medical technology, and growing awareness about hearing health. The rising geriatric population, coupled with the growing incidence of age-related hearing loss, is fueling demand for tinnitus management solutions. Additionally, the impact of noise pollution on hearing health is driving the need for preventive measures and treatment options. Technological advancements in hearing aids and sound therapy devices, coupled with research initiatives focused on understanding the underlying mechanisms of tinnitus, are contributing to market growth.

Market Restraints:

Despite the growing demand for ringing ears treatment, the market faces challenges related to limited treatment efficacy and high costs. Tinnitus is a complex condition with diverse etiologies, making it challenging to develop universal treatment solutions. Moreover, the subjective nature of tinnitus symptoms and individual variability in patient response to treatment pose challenges for healthcare providers. Additionally, the high cost of advanced treatment options, such as cochlear implants and neuromodulation devices, limits access for certain patient populations. Regulatory hurdles and reimbursement issues further compound the challenges faced by stakeholders in the ringing ears treatment market.

Market Opportunities:

The ringing ears treatment market presents significant opportunities for innovation and collaboration across industry stakeholders. Advancements in neuroscience, digital health, and personalized medicine offer new avenues for developing targeted and effective treatment options for tinnitus patients. Integrating artificial intelligence and machine learning algorithms into diagnostic and therapeutic approaches can enhance treatment outcomes and patient satisfaction. Furthermore, expanding research efforts focused on understanding the neurobiological mechanisms of tinnitus and identifying novel therapeutic targets can drive innovation in the field. Collaboration between academia, industry, and patient advocacy groups is essential for advancing tinnitus research and improving patient care.

Key Questions Addressed in the Report:

• What is the Expected Value CAGR of the Ringing Ears Treatment Market?
• What are the Key Factors Driving the Growth of the Ringing Ears Treatment Market?
• Which Region Holds the Largest Market Share in the Ringing Ears Treatment Market?
• Who are the Key Players in the Global Ringing Ears Treatment Market?
• What Strategies are Adopted by Leading Companies to Sustain Growth in the Ringing Ears Treatment Market?

Competitive Landscape and Business Strategies:

Leading players in the ringing ears treatment market include Cochlear Limited, Widex A/S, and Neuromod Devices Limited. These companies focus on research and development initiatives, strategic partnerships, and product innovation to maintain their competitive edge. Strategies such as launching advanced hearing aids with tinnitus masking features, expanding market presence through distribution agreements, and investing in clinical trials for novel therapies are commonly employed to drive growth. Additionally, patient education and advocacy programs play a crucial role in raising awareness about tinnitus and reducing stigma associated with the condition.

Key Companies Profiled:

• Cochlear Limited
• Widex A/S
• Neuromod Devices Limited
• Oticon, Inc.
• GN Store Nord A/S
• Starkey Hearing Technologies
• Advanced Bionics AG
• MED-EL Medical Electronics
• Sonova Holding AG
• Natus Medical Incorporated

Ringing Ears Treatment Market Segmentation:

By Treatment Type:

• Sound Therapy
• Cognitive Behavioral Therapy
• Medications
• Neuromodulation
• Hearing Aids
• Others

By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Ringing Ears Treatments Innovation / Key Development Trends
• 3.3. New Launches / Procedures/Patents

4. Market Background

• 4.1. Macro-Economic Factors
  • 4.1.1. Global GDP Growth Outlook
  • 4.1.2. Global Healthcare Expenditure Outlook
  • 4.1.3. Emerging Countries Healthcare and Development Outlook
• 4.2. Forecast Factors - Relevance & Impact
  • 4.2.1. Adoption of Device Product
  • 4.2.2. Prevalence of Tinnitus
  • 4.2.3. Reimbursement scenario
  • 4.2.4. Expansion by leading manufacturer in emerging geographies
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunity Analysis

5. Market Context

• 5.1. List of Manufacturer and Supplier
• 5.2. Usage/ Adoption Analysis
• 5.3. Disease Epidemiology
• 5.4. Promotional Strategies by Key Manufacturer
• 5.5. List of FDA approved Ringing Ears Treatment Devices

6. COVID19 Crisis Analysis

• 6.1. Current COVID19 Statistics and Probable Future Impact
• 6.2. Current GDP Projection and Probable Impact
• 6.3. Current Economic Projection as compared t2008 financial analysis
• 6.4. COVID19 and Impact Analysis
  • 6.4.1. Revenue by Product
  • 6.4.2. Revenue by Country
• 6.5. 2021 Market Scenario
• 6.6. Quarter by Quarter Forecast
• 6.7. Projected recovery Quarter
• 6.8. Recovery Scenario- Short term, Midterm and Long Term Impact

7. Ringing Ears Treatment Market -Pricing Analysis

• 7.1. Regional Pricing Analysis by Indication
• 7.2. Pricing Break-up
  • 7.2.1. Manufacturer Level Pricing
  • 7.2.2. Distributor Level Pricing
• 7.3. Average Pricing Analysis Benchmark

8. Global Ringing Ears Treatment Market Volume ('000) Units Analysis 2019-2023 and Forecast, 2024-2031

• 8.1. Historical Market Volume ('000) Units Analysis, 2019-2023
• 8.2. Current and Future Market Volume ('000) Units Projections, 2024-2031
  • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Ringing Ears Treatment Market Value (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2031
  • 10.3.1. Devices
    • 10.3.1.1. Sound Masking Devices
    • 10.3.1.2. Notched Music Devices
    • 10.3.1.3. Hearing Aids
  • 10.3.2. Drugs
    • 10.3.2.1. Tricyclic Antidepressants
    • 10.3.2.2. Antianxiety
    • 10.3.2.3. Anticonvulsants
• 10.4. Market Attractiveness Analysis by Product

11. Global Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, by Indication, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2024-2031
  • 11.3.1. Subjective Tinnitus
  • 11.3.2. Objective Tinnitus
  • 11.3.3. Market Attractiveness Analysis by Indication

12. Global Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2024-2031
  • 12.3.1. Audiology Centres
  • 12.3.2. ENT Clinics
  • 12.3.3. Hospitals
  • 12.3.4. E-Commerce
• 12.4. Market Attractiveness Analysis by Distribution Channel

13. Global Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
• 13.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2031
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis by Region

14. North America Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 14.3.1. by Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. by Product
  • 14.3.3. by Indication
  • 14.3.4. by Distribution Channel
• 14.4. Market Attractiveness Analysis
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis

15. Latin America Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 15.3.1. by Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. by Product
  • 15.3.3. by Indication
  • 15.3.4. by Distribution Channel
• 15.4. Market Attractiveness Analysis
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis

16. Europe Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 16.3.1. by Country
    • 16.3.1.1. U.K.
    • 16.3.1.2. Germany
    • 16.3.1.3. France
    • 16.3.1.4. Italy
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. BENELUX
    • 16.3.1.8. Rest of Europe
  • 16.3.2. by Product
  • 16.3.3. by Indication
  • 16.3.4. by Distribution Channel
• 16.4. Market Attractiveness Analysis
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis

17. South Asia Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 17.3.1. by Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. by Product
  • 17.3.3. by Indication
  • 17.3.4. by Distribution Channel
• 17.4. Market Attractiveness Analysis
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis

18. East Asia Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 18.3.1. by Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
    • 18.3.1.4. Rest of East Asia
  • 18.3.2. by Product
  • 18.3.3. by Indication
  • 18.3.4. by Distribution Channel
• 18.4. Market Attractiveness Analysis
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis

19. Oceania Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 19.3.1. by Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. by Product
  • 19.3.3. by Indication
  • 19.3.4. by Distribution Channel
• 19.4. Market Attractiveness Analysis
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
  • 20.3.1. by Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. Northern Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. by Product
  • 20.3.3. by Indication
  • 20.3.4. by Distribution Channel
• 20.4. Market Attractiveness Analysis
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis

21. Emerging Countries Ringing Ears Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 21.1. Introduction
  • 21.1.1. Market Value Proportion Analysis, by Key Countries
  • 21.1.2. Global Vs. Country Growth Comparison
• 21.2. U.S. Ringing Ears Treatment Market Analysis
  • 21.2.1. by Product
  • 21.2.2. by Indication
  • 21.2.3. by Distribution Channel
• 21.3. Canada Ringing Ears Treatment Market Analysis
  • 21.3.1. by Product
  • 21.3.2. by Indication
  • 21.3.3. by Distribution Channel
• 21.4. Mexico Ringing Ears Treatment Market Analysis
  • 21.4.1. by Product
  • 21.4.2. by Indication
  • 21.4.3. by Distribution Channel
• 21.5. Brazil Ringing Ears Treatment Market Analysis
  • 21.5.1. by Product
  • 21.5.2. by Indication
  • 21.5.3. by Distribution Channel
• 21.6. U.K. Ringing Ears Treatment Market Analysis
  • 21.6.1. by Product
  • 21.6.2. by Indication
  • 21.6.3. by Distribution Channel
• 21.7. Germany Ringing Ears Treatment Market Analysis
  • 21.7.1. by Product
  • 21.7.2. by Indication
  • 21.7.3. by Distribution Channel
• 21.8. France Ringing Ears Treatment Market Analysis
  • 21.8.1. by Product
  • 21.8.2. by Indication
  • 21.8.3. by Distribution Channel
• 21.9. Italy Ringing Ears Treatment Market Analysis
  • 21.9.1. by Product
  • 21.9.2. by Indication
  • 21.9.3. by Distribution Channel
• 21.10. Spain Ringing Ears Treatment Market Analysis
  • 21.10.1. by Product
  • 21.10.2. by Indication
  • 21.10.3. by Distribution Channel
• 21.11. BENELUX Ringing Ears Treatment Market Analysis
  • 21.11.1. by Product
  • 21.11.2. by Indication
  • 21.11.3. by Distribution Channel
• 21.12. Russia Ringing Ears Treatment Market Analysis
  • 21.12.1. by Product
  • 21.12.2. by Indication
  • 21.12.3. by Distribution Channel
• 21.13. China Ringing Ears Treatment Market Analysis
  • 21.13.1. by Product
  • 21.13.2. by Indication
  • 21.13.3. by Distribution Channel
• 21.14. Japan Ringing Ears Treatment Market Analysis
  • 21.14.1. by Product
  • 21.14.2. by Indication
  • 21.14.3. by Distribution Channel
• 21.15. South Korea Ringing Ears Treatment Market Analysis
  • 21.15.1. by Product
  • 21.15.2. by Indication
  • 21.15.3. by Distribution Channel
• 21.16. India Ringing Ears Treatment Market Analysis
  • 21.16.1. by Product
  • 21.16.2. by Indication
  • 21.16.3. by Distribution Channel
• 21.17. ASEAN Ringing Ears Treatment Market Analysis
  • 21.17.1. by Product
  • 21.17.2. by Indication
  • 21.17.3. by Distribution Channel
• 21.18. Australia Ringing Ears Treatment Market Analysis
  • 21.18.1. by Product
  • 21.18.2. by Indication
  • 21.18.3. by Distribution Channel
• 21.19. New Zealand Ringing Ears Treatment Market Analysis
  • 21.19.1. by Product
  • 21.19.2. by Indication
  • 21.19.3. by Distribution Channel
• 21.20. GCC Countries Ringing Ears Treatment Market Analysis
  • 21.20.1. by Product
  • 21.20.2. by Indication
  • 21.20.3. by Distribution Channel
• 21.21. Turkey Ringing Ears Treatment Market Analysis
  • 21.21.1. by Product
  • 21.21.2. by Indication
  • 21.21.3. by Distribution Channel
• 21.22. South Africa Ringing Ears Treatment Market Analysis
  • 21.22.1. by Product
  • 21.22.2. by Indication
  • 21.22.3. by Distribution Channel

22. Market Structure Analysis

• 22.1. Market Analysis by Tier of Companies
• 22.2. Market Share Analysis of Top Players

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Competition Benchmarking
• 23.3. Competition Deep Dive
  • 23.3.1. Pfizer Inc.
    • 23.3.1.1. Overview
    • 23.3.1.2. Product Portfolio
    • 23.3.1.3. Analyst Commentary
    • 23.3.1.4. Key Financials
    • 23.3.1.5. Recent Developments
    • 23.3.1.6. Sales Footprint
    • 23.3.1.7. Strategy Overview
      • 23.3.1.7.1. Marketing Strategy
      • 23.3.1.7.2. Product Strategy
      • 23.3.1.7.3. Channel Strategy
  • 23.3.2. Sanofi
    • 23.3.2.1. Overview
    • 23.3.2.2. Product Portfolio
    • 23.3.2.3. Analyst Commentary
    • 23.3.2.4. Key Financials
    • 23.3.2.5. Recent Developments
    • 23.3.2.6. Sales Footprint
    • 23.3.2.7. Strategy Overview
      • 23.3.2.7.1. Marketing Strategy
      • 23.3.2.7.2. Product Strategy
      • 23.3.2.7.3. Channel Strategy
  • 23.3.3. Teva Pharmaceutical
    • 23.3.3.1. Overview
    • 23.3.3.2. Product Portfolio
    • 23.3.3.3. Analyst Commentary
    • 23.3.3.4. Key Financials
    • 23.3.3.5. Recent Developments
    • 23.3.3.6. Sales Footprint
    • 23.3.3.7. Strategy Overview
      • 23.3.3.7.1. Marketing Strategy
      • 23.3.3.7.2. Product Strategy
      • 23.3.3.7.3. Channel Strategy
  • 23.3.4. GlaxoSmithKline
    • 23.3.4.1. Overview
    • 23.3.4.2. Product Portfolio
    • 23.3.4.3. Analyst Commentary
    • 23.3.4.4. Key Financials
    • 23.3.4.5. Recent Developments
    • 23.3.4.6. Sales Footprint
    • 23.3.4.7. Strategy Overview
      • 23.3.4.7.1. Marketing Strategy
      • 23.3.4.7.2. Product Strategy
      • 23.3.4.7.3. Channel Strategy
  • 23.3.5. Eli Lilly and Co.
    • 23.3.5.1. Overview
    • 23.3.5.2. Product Portfolio
    • 23.3.5.3. Analyst Commentary
    • 23.3.5.4. Key Financials
    • 23.3.5.5. Recent Developments
    • 23.3.5.6. Sales Footprint
    • 23.3.5.7. Strategy Overview
      • 23.3.5.7.1. Marketing Strategy
      • 23.3.5.7.2. Product Strategy
      • 23.3.5.7.3. Channel Strategy
  • 23.3.6. Bayer AG
    • 23.3.6.1. Overview
    • 23.3.6.2. Product Portfolio
    • 23.3.6.3. Analyst Commentary
    • 23.3.6.4. Key Financials
    • 23.3.6.5. Recent Developments
    • 23.3.6.6. Sales Footprint
    • 23.3.6.7. Strategy Overview
      • 23.3.6.7.1. Marketing Strategy
      • 23.3.6.7.2. Product Strategy
      • 23.3.6.7.3. Channel Strategy
  • 23.3.7. Takeda Pharmaceutical Company Ltd.
    • 23.3.7.1. Overview
    • 23.3.7.2. Product Portfolio
    • 23.3.7.3. Analyst Commentary
    • 23.3.7.4. Key Financials
    • 23.3.7.5. Recent Developments
    • 23.3.7.6. Sales Footprint
    • 23.3.7.7. Strategy Overview
      • 23.3.7.7.1. Marketing Strategy
      • 23.3.7.7.2. Product Strategy
      • 23.3.7.7.3. Channel Strategy
  • 23.3.8. Boehringer Ingelheim
    • 23.3.8.1. Overview
    • 23.3.8.2. Product Portfolio
    • 23.3.8.3. Analyst Commentary
    • 23.3.8.4. Key Financials
    • 23.3.8.5. Recent Developments
    • 23.3.8.6. Sales Footprint
    • 23.3.8.7. Strategy Overview
      • 23.3.8.7.1. Marketing Strategy
      • 23.3.8.7.2. Product Strategy
      • 23.3.8.7.3. Channel Strategy
  • 23.3.9. Merck & Co.
    • 23.3.9.1. Overview
    • 23.3.9.2. Product Portfolio
    • 23.3.9.3. Analyst Commentary
    • 23.3.9.4. Key Financials
    • 23.3.9.5. Recent Developments
    • 23.3.9.6. Sales Footprint
    • 23.3.9.7. Strategy Overview
      • 23.3.9.7.1. Marketing Strategy
      • 23.3.9.7.2. Product Strategy
      • 23.3.9.7.3. Channel Strategy
  • 23.3.10. Abbivie
    • 23.3.10.1. Overview
    • 23.3.10.2. Product Portfolio
    • 23.3.10.3. Analyst Commentary
    • 23.3.10.4. Key Financials
    • 23.3.10.5. Recent Developments
    • 23.3.10.6. Sales Footprint
    • 23.3.10.7. Strategy Overview
      • 23.3.10.7.1. Marketing Strategy
      • 23.3.10.7.2. Product Strategy
      • 23.3.10.7.3. Channel Strategy
  • 23.3.11. Starkey Laboratories, Inc.
    • 23.3.11.1. Overview
    • 23.3.11.2. Product Portfolio
    • 23.3.11.3. Analyst Commentary
    • 23.3.11.4. Key Financials
    • 23.3.11.5. Recent Developments
    • 23.3.11.6. Sales Footprint
    • 23.3.11.7. Strategy Overview
      • 23.3.11.7.1. Marketing Strategy
      • 23.3.11.7.2. Product Strategy
      • 23.3.11.7.3. Channel Strategy
  • 23.3.12. GN Hearing A/S
    • 23.3.12.1. Overview
    • 23.3.12.2. Product Portfolio
    • 23.3.12.3. Analyst Commentary
    • 23.3.12.4. Key Financials
    • 23.3.12.5. Recent Developments
    • 23.3.12.6. Sales Footprint
    • 23.3.12.7. Strategy Overview
      • 23.3.12.7.1. Marketing Strategy
      • 23.3.12.7.2. Product Strategy
      • 23.3.12.7.3. Channel Strategy
  • 23.3.13. Widex A/S
    • 23.3.13.1. Overview
    • 23.3.13.2. Product Portfolio
    • 23.3.13.3. Analyst Commentary
    • 23.3.13.4. Key Financials
    • 23.3.13.5. Recent Developments
    • 23.3.13.6. Sales Footprint
    • 23.3.13.7. Strategy Overview
      • 23.3.13.7.1. Marketing Strategy
      • 23.3.13.7.2. Product Strategy
      • 23.3.13.7.3. Channel Strategy
  • 23.3.14. Oticon Inc.
    • 23.3.14.1. Overview
    • 23.3.14.2. Product Portfolio
    • 23.3.14.3. Analyst Commentary
    • 23.3.14.4. Key Financials
    • 23.3.14.5. Recent Developments
    • 23.3.14.6. Sales Footprint
    • 23.3.14.7. Strategy Overview
      • 23.3.14.7.1. Marketing Strategy
      • 23.3.14.7.2. Product Strategy
      • 23.3.14.7.3. Channel Strategy
  • 23.3.15. Neuromod Devices Ltd.
    • 23.3.15.1. Overview
    • 23.3.15.2. Product Portfolio
    • 23.3.15.3. Analyst Commentary
    • 23.3.15.4. Key Financials
    • 23.3.15.5. Recent Developments
    • 23.3.15.6. Sales Footprint
    • 23.3.15.7. Strategy Overview
      • 23.3.15.7.1. Marketing Strategy
      • 23.3.15.7.2. Product Strategy
      • 23.3.15.7.3. Channel Strategy
  • 23.3.16. Neuromonics, Inc.
    • 23.3.16.1. Overview
    • 23.3.16.2. Product Portfolio
    • 23.3.16.3. Analyst Commentary
    • 23.3.16.4. Key Financials
    • 23.3.16.5. Recent Developments
    • 23.3.16.6. Sales Footprint
    • 23.3.16.7. Strategy Overview
      • 23.3.16.7.1. Marketing Strategy
      • 23.3.16.7.2. Product Strategy
      • 23.3.16.7.3. Channel Strategy
  • 23.3.17. Puretone Ltd.
    • 23.3.17.1. Overview
    • 23.3.17.2. Product Portfolio
    • 23.3.17.3. Analyst Commentary
    • 23.3.17.4. Key Financials
    • 23.3.17.5. Recent Developments
    • 23.3.17.6. Sales Footprint
    • 23.3.17.7. Strategy Overview
      • 23.3.17.7.1. Marketing Strategy
      • 23.3.17.7.2. Product Strategy
      • 23.3.17.7.3. Channel Strategy
  • 23.3.18. Signia
    • 23.3.18.1. Overview
    • 23.3.18.2. Product Portfolio
    • 23.3.18.3. Analyst Commentary
    • 23.3.18.4. Key Financials
    • 23.3.18.5. Recent Developments
    • 23.3.18.6. Sales Footprint
    • 23.3.18.7. Strategy Overview
      • 23.3.18.7.1. Marketing Strategy
      • 23.3.18.7.2. Product Strategy
      • 23.3.18.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

관련자료